Chengfen Xing

2.6k citations
89 papers · 2.1k indexed · h-index 27
Topics
Nanoplatforms for cancer theranostics (34 papers)Luminescence and Fluorescent Materials (29 papers)Photodynamic Therapy Research Studies (11 papers)
Partner nations
ChinaNetherlandsRussia

In The Last Decade

Chengfen Xing

85 papers receiving 2.1k citations

Peers

Chengfen Xing
Comparison fields: 5 of 111
  • Materials Chemistry 1.1k
  • Biomedical Engineering 905
  • Molecular Biology 465
  • Biomaterials 415
  • Organic Chemistry 361
Replace Félix Busquè with:
Félix Busquè Spain
Nan Zheng China
Cristina Satriano Italy
Ningning Wang China
Hanlin Ou China
Jae Hong Kim South Korea
Miodrag Mićić United States
Yu Yi China
Qiong Wu China
Chengfen Xing relative to Félix Busquè Spain Félix Busquè's profile →
Citations per field
00.5×1.5×
Félix Busquè · 1×
Citations per year

Countries citing papers authored by Chengfen Xing

Since Specialization
Citations

This map shows the geographic impact of Chengfen Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfen Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfen Xing more than expected).

Fields of papers citing papers by Chengfen Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengfen Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfen Xing. The network helps show where Chengfen Xing may publish in the future.

Co-authorship network of co-authors of Chengfen Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Chengfen Xing. A scholar is included among the top collaborators of Chengfen Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengfen Xing. Chengfen Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 2
4 1
5 11
6 5
7 7
8 7
9 36
10 6
11 11
12 16
13 12
14 7
15 27
16 61
17 4
18 45
19 7
20 26

About Chengfen Xing

Chengfen Xing is a scholar working on Biomaterials, Materials Chemistry and Biomedical Engineering, having authored 89 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (34 papers), Luminescence and Fluorescent Materials (29 papers) and Photodynamic Therapy Research Studies (11 papers). The work is most often cited by research in Biomaterials (415 citations), Materials Chemistry (1.1k citations) and Biomedical Engineering (905 citations). Chengfen Xing has collaborated with scholars based in China, Netherlands and Russia. Frequent co-authors include Shu Wang, Libing Liu, Hongwei Tang, Hongbo Yuan, Yong Zhan, Dong Gao, Qingling Xu, Qiong Yang, Xuli Feng and Fengting Lv. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026